BioNTech SE (BNTX) EBT (2018 - 2025)

BioNTech SE (BNTX) has 8 years of EBT data on file, last reported at -$264.7 million in Q4 2025.

• For the quarter ending Q4 2025, EBT fell 182.24% year-over-year to -$264.7 million; the trailing twelve-month figure through Dec 2025 stood at -$1.2 billion (down 58.48% YoY), and the FY2025 full-year result was -$1.2 billion, down 63.94% from the prior year.
• EBT fell to -$264.7 million in Q4 2025, from $28.9 million in the prior quarter.
• In the past five years, EBT ranged from a high of $5.6 billion in Q1 2022 to a low of -$867.8 million in Q2 2024.
• A 5-year average of $1.5 billion and a median of $517.7 million in 2023 frame the typical range for EBT.
• Across the five-year window, EBT soared 2199836406.41% in 2021 and tumbled 182.24% in 2025, its largest moves.
• Tracing BNTX's EBT over 5 years: stood at $5.4 billion in 2021, then tumbled by 39.98% to $3.2 billion in 2022, then tumbled by 77.95% to $713.6 million in 2023, then slumped by 54.89% to $321.9 million in 2024, then plunged by 182.24% to -$264.7 million in 2025.
• Business Quant data shows BNTX's EBT at -$264.7 million in Q4 2025, $28.9 million in Q3 2025, and -$455.8 million in Q2 2025.